Correlation Between Qualigen Therapeutics and CreditRiskMonitor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and CreditRiskMonitor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and CreditRiskMonitor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and CreditRiskMonitorCom, you can compare the effects of market volatilities on Qualigen Therapeutics and CreditRiskMonitor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of CreditRiskMonitor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and CreditRiskMonitor.

Diversification Opportunities for Qualigen Therapeutics and CreditRiskMonitor

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Qualigen and CreditRiskMonitor is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and CreditRiskMonitorCom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CreditRiskMonitorCom and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with CreditRiskMonitor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CreditRiskMonitorCom has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and CreditRiskMonitor go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and CreditRiskMonitor

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the CreditRiskMonitor. In addition to that, Qualigen Therapeutics is 1.66 times more volatile than CreditRiskMonitorCom. It trades about -0.13 of its total potential returns per unit of risk. CreditRiskMonitorCom is currently generating about 0.32 per unit of volatility. If you would invest  268.00  in CreditRiskMonitorCom on August 29, 2024 and sell it today you would earn a total of  77.00  from holding CreditRiskMonitorCom or generate 28.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Qualigen Therapeutics  vs.  CreditRiskMonitorCom

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
CreditRiskMonitorCom 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in CreditRiskMonitorCom are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, CreditRiskMonitor showed solid returns over the last few months and may actually be approaching a breakup point.

Qualigen Therapeutics and CreditRiskMonitor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and CreditRiskMonitor

The main advantage of trading using opposite Qualigen Therapeutics and CreditRiskMonitor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, CreditRiskMonitor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CreditRiskMonitor will offset losses from the drop in CreditRiskMonitor's long position.
The idea behind Qualigen Therapeutics and CreditRiskMonitorCom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.